With nearly 30 million Americans living with diabetes and 86 million more at risk of developing diabetes, you might expect diabetes to be a top priority for Congress. But it’s not. That’s why members of Congress need to hear from us. In fact, it’s been five years since the last congressional hearing on diabetes and...
During September and October, the Society participated in two important international meetings related to Endocrine Disrupting Chemicals (EDCs). The Society was the only scientific organization participating and, as such, it was able to share the Society’s latest Scientific Statement on EDCs and link health impacts to EDCs, and was seen as a trusted policy advisor....
Today, more than a third of the adult population is affected by obesity and this number continues to rise. With this in mind, the Society recognizes the important role that our members can play and we are pleased to announce our participation in the first-ever National Obesity Care Week, November 1-7, a grassroots advocacy campaign...
NIH Funding Announcements of Interest to Endocrine Scientists
On September 14, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), in collaboration with the National Cancer Institute (NCI), published a series of RFAs (Requests for Applications) that are intended to stimulate multi-disciplinary research on developmental issues for individuals and families affected by differences or disorders of sex development (DSD),...
Government Shutdown Avoided with Passage of Short-Term Funding Bill
The U.S. House of Representatives and Senate passed legislation on September 30 to fund the government through December 11 and avoid a federal shutdown. The legislation, known as a Continuing Resolution (CR), funds the government at fiscal year (FY) 2015 levels minus .21 percent to ensure that funding does not exceed statutory budget caps. The...
Some chemicals in cosmetics and other personal products (shampoo, soap, toothpaste, etc.) have been linked to a variety of serious health effects in women, men, and children. Currently, the U.S. Food and Drug Administration (FDA) has very limited authority and resources to regulate cosmetics, so the agency is not screening for chemicals that could be...
On September 17 the Endocrine Society helped sponsor the 3rd annual “Rally for Medical Research Hill Day” in Washington, D.C. The event proved to be an extraordinary day on Capitol Hill with nearly 300 people from more than 120 different organizations coming together, from 40 states, plus Washington D.C. to visit House and Senate offices...
As part of a comprehensive approach to enhance the visibility of endocrinology among research funding agencies, the Society participated in the June 4 meeting of the National Advisory Child Health and Human Development Council (NACHHD). The Council advises the director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) on...
Endocrinology Advocacy
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
